P 65: Soluble CD18 as an Inflammation Reducing Agent in Parkinson\'s Disease

نویسندگان

  • Sara Mehdipour Islamic Azad University, Mashhad Branch, Mashhad, Iran
چکیده مقاله:

Parkinson's disease (PD) is a very common neurodegenerative disease among the elderly population. Current treatments for Parkinson’s disease are based on symptom therapy but not the underlying cause of the disease. This disorder is caused neuronal death which triggers the activation of resident glial cells. This situation leads to neuroinflammation in the central nervous system. Activated glial cells produce molecular modulators such as cytokines and chemokines which induce an inflammatory environment that causes the recruitment of peripheral leukocytes. In physiological situation migration of leukocytes through blood brain barrier ( BBB ) into central nervous system  is constrict limited due to presence of tight junctions and cell adhesion molecules ( CAMs ) but in an inflammatory environment because of the overexpression of intercellular CAM-1 ( ICAM-1 ) and vascular CAM-1 ( VCAM-1 ) on the BBB' endothelium the circulating immune cells can migrate into the brain. ICAM-1 is a glycoprotein on the surface of the endothelial and immune cells which attach to the integrin type CD18. Some studies have shown that soluble CD18 could block the receptor of CD18 in other places in body so I hypothesized that using of soluble CD18 can block receptors on the BBB's endothelium and avoid entry of peripheral leukocytes into the brain. If it happens it can prevent further cell death in the brain stem so progress of the disease will be so much slower.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

p 65: soluble cd18 as an inflammation reducing agent in parkinson's disease

parkinson's disease (pd) is a very common neurodegenerative disease among the elderly population. current treatments for parkinson’s disease are based on symptom therapy but not the underlying cause of the disease. this disorder is caused neuronal death which triggers the activation of resident glial cells. this situation leads to neuroinflammation in the central nervous system. activated ...

متن کامل

P 131: Connection Process Inflammation and Improvement Alzheimer’s Disease

Platelet aggregation beta amyloid main causes inflammation of neurons in Alzheimer’s disease. In fact, creating this inflammation due to inappropriate actions in blood brain barrier (BBB) and astrocyte and microglia during the last century that studies conducted in this case nothing has been found. The only thing that can be done to prevent and reduce pro-inflammatory factors such as cyto...

متن کامل

P 101: Ginger and Honey Mixture as an Anti-Inflammatory Drug in Neuroinflammation:Alzheimer Disease

Nowadays, many people prefer to use herbal remedies instead of chemical treatments, because of a fewer side effects. It seems that herbal drugs can be useful to neuroinflammation diseases like Alzheimer. Alzheimer Disease (AD) is caused by the oxidative stress and inflammatory compounds such as cytokine and beta-amyloid. It causes learning problems due to damage in cells in the hippocampus area...

متن کامل

P 141: Mesenchymal Stem Cells as Treatment in Neuroinflammatory Disease

Mesenchymal stem cells can be obtained from deferent tissues like adipose tissue, umbilical cord, placenta, skin, bone marrow, etc. These cells have regulatory effects on all types of immune cells such as dendritic cell, natural killers and lymphocytes. Mesenchymal stem cells induce inhibitory phenotypes of Antigen Presenting Cells (APCs) following their activity. They also change T cells pheno...

متن کامل

P 123: A Promising Approach in Inflammation Management, Cytokine Therapy for Alzheimer’s Disease

Alzheimer’s disease (AD) is a neurodegenerative disease characterized by cognitive and other CNS impairments which is increasing worldwide and poses a major public health problem, yet no effective treatments are found and available drugs only alleviate the symptoms temporarily. Postmortem analyses on the brains of AD patients and observed lower risk of AD in NSAIDs users among other studi...

متن کامل

P 118: Osteopontin: An Early Player in Neuroinflammation Disease

Osteopontin also known as bone sialoprotein (BSP). Osteopontin role as a linking protein. it is an extracellular structural protein and therefore an organic component of bone. Osteoprontin (OPN) binds to several integrin receptors containing α4β1, α9β1, and α9β4 expressed by leukocytes. These receptors have been well-stable to function in cell adhesion, migratio...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


عنوان ژورنال

دوره 5  شماره 2

صفحات  96- 96

تاریخ انتشار 2017-04

با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023